HR 8467
116th Congress
House
Health
Drug therapy
Employee benefits and pensions
Health care costs and insurance
Health care coverage and access
Insurance industry and regulation
Medicaid
Medicare
Prescription drugs
Access to Rare Indications Act of 2020
Introduced: September 30, 2020
Introduced by:
Thompson, Mike
Democratic
· California
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 30, 2020
Introduced in House
Plain-English summary
Access to Rare Indications Act of 2020
This bill prohibits coverage exclusions or limitations under the Medicare prescription drug benefit, Medicaid, or private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals and that are supported by the National Institutes of Health Rare Diseases Clinical Research Network).
What's happening now
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees of jurisdiction
2
Cosponsors
1